NXTCL — NextCell Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK126.39m
- SEK94.06m
- SEK13.70m
Brief: NextCell Pharma Q3 Operating Loss Widens To SEK 9.3 Mln
Brief: European Patent Office Intends To Grant NextCell Pharma Patent For Selection Algorithm
Brief: Nextcell Pharma Q2 Operating Loss Widens To SEK 10.2 Million
Brief: Nextcell Invests In Car-T Technology
Brief: Nextcell Pharma Q1 Operating Income Rises To SEK 1.34 Mln
Brief: Nextcell Pharma Enteres Into A Collaboration Agreement With T.A.D.1
Brief: Nextcell Q4 Operating Loss At SEK 4.5 Mln
Brief: NextCell To Begin Treatment With Medium Dose In COVID-19
Brief: Nextcell Pharma Appoints Patrik Fagerholm As Interim CFO
Brief: NextCell Pharma Q3 Operating Income Up At SEK 0.9 Mln
Brief: NextCell Enters CAR-T Joint Venture
Brief: Nextcell Pharma Q2 Operating Loss Widens To SEK 8.1 Mln
Brief: NextCell Welcomes Consensus Sverige Selectas As Shareholder
Brief: Nextcell Invests In Full-Scale Production Facility
Brief: Nextcell Pharma Q1 Operating Loss At SEK 17.7 Mln
Brief: NextCell Pharma Completes Directed Issue To Strategic Partner
Brief: Nextcell Pharma's Rights Issue Oversubscribed
Brief: Nextcell Pharma: ProTrans Trial Meets Primary Endpoint
Brief: NextCell Pharma Board Intends To Decide On Fully Guaranteed Rights Issue Of Up To Around SEK 150 Mln